Skip to main content
Journal of Pharmacy & Bioallied Sciences logoLink to Journal of Pharmacy & Bioallied Sciences
. 2023 Jul 5;15(Suppl 1):S122–S126. doi: 10.4103/jpbs.jpbs_434_22

Evaluation of the Head and Neck Surgery During the Pandemic COVID-19: A Tertiary Care Center Study

Sreedevi Janapareddi 1, Samir Mansuri 2,, Sunil N Khot 3, Surinder S Jamwal 4, Manoj K Kanta 5, Sankar Narayana Sarma 6
PMCID: PMC10466622  PMID: 37654388

ABSTRACT

Introduction:

There is a notable shift in the attitude of the admission, review, diagnostics, and follow-up of patients for all the medical sectors and of particular interest of cancer patients. The present study aimed to elaborate on the identification of patients with head and neck cancers (HNCs); the diagnostics, the triage, and the best treatment plan were all evaluated and at the same time compared with the years before the pandemic at a tertiary care center that caters to various other patients also.

Materials and Methods:

A retrospective observational clinical study was conducted at the tertiary care center that catered to all the medical specialties. The demographics, the patient characteristics, the surgeries performed, complications, mortality, and readmissions were evaluated and compared with the pre-coronavirus disease (COVID) time.

Results:

There was a significant difference in the complications for the pre-COVID time when the groups were compared for the matched pair.

Conclusion:

The proper screening and triaging of the patients will help in the early intervention of the patients with the HNCs.

KEYWORDS: Covid-19, head and neck surgery, pandemic

INTRODUCTION

The World Health Organization (WHO) proclaimed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be a pandemic at the start of the year 2020.[1] The world’s healthcare system has to be completely restructured as a result of the sudden increase in coronavirus disease 2019 (COVID-19) cases. There have been significant negative effects for cancer patients as a result of the state-imposed lockout and the redirection of personnel and resources to the care of COVID-19 patients who are severely ill.[2] There is a notable shift in the attitude of the admission, review, diagnostics, and follow-up of patients for all the medical sectors and of particular interest of cancer patients. There is a chance that this will lead to a drop in survival rates, with high-income nations experiencing drops of 5–10%.[2] In India, 30–40% of all cancer cases are head and neck cancers (HNCs).[3] Due to the possibility of aerosol formation during evaluation and treatment, patients and healthcare professionals participating in HNC care confront additional challenges.[4] In the initial stages of the pandemic, the doctors had a lot of disagreement over the best treatment for HNC patients. Over the last two years, the delivery of the best treatment for these patients has been well established.[5-10] In the present study, the aim was to elaborate on the identification of the patients with the HNCs; the diagnostics, the triage, and the best treatment plan were all evaluated and at the same time compared with the years before the pandemic at a tertiary care center that caters to various other patients also.

MATERIAL AND METHODS

A retrospective observational clinical study was conducted at the tertiary care center that catered to all the medical specialties. The study period was between April 2020 and December 2020 for a period of 9 months. The Institutional Ethical Committee granted this retroactive review an exemption from the requirement for ethical clearance. All participants provided their written consent after being fully informed.

Before surgery workup

The patient was evaluated for the symptoms of COVID. Along with that, they were advised reverse transcriptase–polymerase chain reaction (RT-PCR) tests; once the tests were obtained, the patients were grouped as positive and negative. The surgery was postponed for the elective surgeries until they got a negative report. The negative cases were admitted to the surgical wards for the needful. The doctors followed all the precautionary methods like personal protective equipment (PPE) wears and followed quarantine methods.

Workflow for patients and operating rooms

The patients were admitted to the surgical ward for the procedures based on the status of the infection of the virus. They were isolated and evaluated. Once the RT-PCR was available, they were put on a waiting period of 48 h and then again evaluated for COVID symptoms. Once confirmed as negative for COVID, they were operated on routinely. If they were confirmed as positive, they were left to wait for at least 3 weeks before the elective surgery was performed. Once all the symptoms subsided, they were treated with universal precautions followed by the additional wearing of the Personal Protective Training (PPT) suits by all the admitted staff. However, for the emergencies, these steps were skipped and routine emergency protocols were followed in the isolation wards. SARS-Cov-2 RT-PCR deep nasal and oropharyngeal swabs were concurrently obtained. In an operating room designed for COVID, patients had emergency surgery. Personnel working in healthcare must wear level 3 PPE. On diagnosed cases of COVID-19, emergent and semi-emergency surgeries were also carried out in an operating room equipped for COVID while wearing level 3 PPE.

Manage airway and anesthesia

The routine examination for the pre-anesthetic check-up was done for the negative patients. The anesthetists were left to choose the intubation methods. The common methods were either pre-procedural tracheostomy or fiberoptic nasal intubation. The routine procedure was followed at the end of the elective cases who were negative for COVID. On the other hand, for the positive cases, intensive care unit’s (ICU) ventilatory and sedation guidelines were followed throughout the surgery with acute respiratory distress syndrome (ARDS) who needed tracheostomies.

Variables are examined

All patients’ COVID-19 statuses were classed as positive, negative, or unknown. The 11-point modified frailty score (MFI) was used to assess the performance status and comorbidities of patients undergoing major head and neck surgeries.[6] The “Clavien-Dindo score” for post-operative complications,[7] commencement of oral feeds, time required for decannulation, 30-day mortality, 30-day hospital readmission rate, and 30-day hospital readmission rate were used to appraise the perioperative outcomes.

RESULTS

A total of 50 cases were finalized in the study. The subjects were all COVID-negative. The procedures are done after the COVID-19 and the various demographics along with the patient characteristics have been described in Table 1. In the pre-COVID time, the numbers of patients that have been admitted for a similar reason was nearly twice as that of the number of subjects that were admitted after the pandemic for the time period of nine months. As described in Table 1, the majority were in the stages III, IV. Modified frailty score and the Clavien-Dindo (CD) score were also considered and compared in the study with that of the non-COVID time. In the comparison, it was found that there was a significant variation in the study characteristics of the stage of the disease, MFI score, reconstruction, and CD score 3. There was no medical staff nor the patients who reported positive after the procedure during the recovery period and follow-up until three weeks. There was no significant difference in the complication rates.

Table 1.

Pre- and post-covid study characteristics

Characteristics COVID –ve patients n=50 Before COVID n=100 P
Age 47.0±10.2 47.1±12.5 NS
Men 35 80 NS
Women 15 20
Subsite NS
 Upper respiratory tract 35 90
 Others 15 10
Stage 0.01
 I,II 10 5
 III, IV 40 95
Surgery NS
 Method 1 10 35
 Method 2 30 45
 Method 3 10 20
MFI Score <0.001
 0 25 85
 1 20 10
 2 5 5
Reconstruction
 Nil 15 75 0.002
 Free-Flap 5 10 <0.001
 Pedicled 30 15
CD Score
 0 30 40 NS
 1 2 5 NS
 2 10 1 NS
 3 3 50 0.002
 4 5 4 NS
 Complications 2% 11% NS
 Readmissions 1 2 NS

Method 1=Transoral resection with no reconstruction; Method 2=Composite resection with laryngectomy; Method 3=Extramucosal surgery (thyroid/parotid/skin)

In Table 2, the comparisons were done after the two groups of pre- and post-COVID were equalized. For the matched pair, analysis with a retrospective cohort was used. A finding of this comparison was that only the Clavien-Dindo score was the only variable that was significantly different than the COVID patients. All other variables were similar in distribution when both groups were matched.

Table 2.

Pre- and post-covid study characteristics that were matched

Characteristics COVID –ve patients n=50 Before COVID n=50 P
Age 47.0±10.2 47.1±12.5 NS
Male 25 27
Female 7 5
Subsite NS
 Upper respiratory tract 35 32
 Others 15 18
Stage NS
 I,II 10 8
 III, IV 40 42
Surgery NS
 Method 1 10 15
 Method 2 30 35
 Method 3 10 10
MFI Score NS
 Zero 25 25
 1 20 20
 2 5 5
CD Score
 Zero 30 18 0.007
 1 2 2
 2 10 8
 3 2 15
 4 5 12

Method 1=Transoral resection with no reconstruction; Method 2=Composite resection with laryngectomy; Method 3=Extramucosal surgery (thyroid/parotid/skin)

DISCUSSION

Many restrictions were imposed on the general public due to the pandemic. The patients who required immediate attention had to suffer under these restrictions. In a country with an inappropriate medical staff and population ratio, attending to elective procedures may be a task to debate about.[11-15] The HNCs may be elective if there is no secondary sepsis and asphyxia. In the present study, the number of patients who attended tertiary care after the pandemic for the treatment of the HNCs and those who normally attended the hospital before the pandemic were compared. The motive was to check for the patient survival as well as the type of surgeries the medical attention was sought for. We also evaluated the change in the procedure for surgeries after the pandemic.

The results showed that there were no mortalities, and no readmissions, the complications were 2% in the pandemic population. The most common procedure was the tracheostomy. The observation made in this study was that there were complications in a greater percentage among the COVID positive patients than the pre-COVID times. This observation is in unison with the study by Werner where he observed that post-operative complications were more in the COVID patients. The findings also pointed to pulmonary complications being the most common. It can be understood that HNC patients might have common etiological factors like tobacco habits, and medical health conditions like immunosuppression, they may also be at risk of infection from these viral strains.[16-20] The elective surgeries have been reported to be postponed for the HNCs. It is established that the treatment should be done within a month after diagnosis. However, if there is a life-threatening risk, then the surgical treatment can be deferred. Nevertheless, this can make the tumor progress by two folds. There may also be a risk of metastasis.[21-25] The pandemic has led to a backlog in the cases. This will put undue pressure on the fast movement of the cases and may hamper the attention of the surgeon. There have been many guidelines put forward to treat patients on how to handle elective cases. In the present study, the only major variation observed for the matched pair patients was with the CD score. This shows a greater complication rate in the post-COVID period. It was evident that normal protocols were not followed after the pandemic.[22-28] This is one of the first studies to evaluate the HNCs in tertiary care centers. Hence, the comparisons were difficult to make. However, the outcomes observed were notable.

The limitation was that the study was retrospective in nature, the study was at a single center, and the population was limited to a specific area. Hence, the findings cannot be generalized to the entire population.

CONCLUSION

Within the limitations, it can be concluded that the complication rates were significantly different before and after the pandemic. There were no other differences in the characters of the population groups. The inclination has been there to defer the elective surgeries. Further studies are encouraged to corroborate the present study’s findings.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

REFERENCES

  • 1.Timeline: WHO's COVID-19 response. [[Last accessed on 2020 Sep 30]]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline .
  • 2.Oncology TL. Safeguarding cancer care in a post COVID-19 world. Lancet Oncol. 2020;21:603. doi: 10.1016/S1470-2045(20)30243-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bhattacharjee A, Chakraborty A, Purkaystha P. Prevalence of head and neck cancers in the north east—An institutional study. Indian J Otolaryngol Head Neck Surg. 2006;8:15–9. doi: 10.1007/BF02907731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL, Sumer BD, et al. Head and neck oncology during the COVID-19 pandemic:Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020;105:104684. doi: 10.1016/j.oraloncology.2020.104684. doi:10.1016/j.oraloncology.2020.104684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Garg PK, Kaul P, Choudhary D, Turaga KK, Singh MP, Tiwari AR, et al. Discordance of COVID-19 guidelines for patients with cancer:A systematic review. J Surg Oncol. 2020;122:93. doi: 10.1002/jso.26110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Adams P, Ghanem T, Stachler R, Hall F, Velanovich V, Rubinfeld I. Frailty as a predictor of morbidity and mortality in inpatient head and neck surgery. JAMA Otolaryngol. 2013;139:783–9. doi: 10.1001/jamaoto.2013.3969. [DOI] [PubMed] [Google Scholar]
  • 7.Monteiro E, Sklar MC, Eskander A, de Almeida JR, Shrime M, Gullane P, et al. Assessment of the Clavien-Dindo classifcation system for complications in head and neck surgery. Laryngoscope. 2014;124:2726–31. doi: 10.1002/lary.24817. [DOI] [PubMed] [Google Scholar]
  • 8.Bindra A, Kajal S, Sikka K. Tracheostomy during COVID19 pandemic:Viewpoint. J Neuroanaesth Crit Care. 2020;7:154–7. [Google Scholar]
  • 9.Doglietto F, Vezzoli M, Gheza F, Lussardi GL, Domenicucci M, Vecchiarelli L, et al. Factors associated with surgical mortality and complications among patients with and without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg. 2020;155:691–702. doi: 10.1001/jamasurg.2020.2713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nahshon C, Bitterman A, Haddad R, Hazzan D, Lavie O. Hazardous postoperative outcomes of unexpected covid-19 infected patients:A call for global consideration of sampling all asymptomatic patients before surgical treatment. World J Surg. 2020;44:2477–81. doi: 10.1007/s00268-020-05575-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Werner MT, Carey RM, Albergotti WG, Lukens JN, Brody RM. Impact of the COVID-19 pandemic on the management of head and neck malignancies. Otolaryngol Head Neck Surg. 2020;162:816–7. doi: 10.1177/0194599820921413. [DOI] [PubMed] [Google Scholar]
  • 12.Gupta A, Arora V, Nair D, Agrawal N, Su YX, Holsinger FC, et al. Status and strategies for the management of head and neck cancer during COVID-19 pandemic:Indian scenario. Head Neck. 2020;42:1460–5. doi: 10.1002/hed.26227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Testing Strategy. [[Last accessed on 2020 Oct 04]]. Available from: https://www.icmr.gov.in/cteststrat.html .
  • 14.Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34:169–78. doi: 10.1200/JCO.2015.61.5906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Liao C-T, Chen H-N, Wen Y-W, Lee SR, Ng S-H, Liu T-W, et al. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma. Eur J Cancer. 2017;72:226–23. doi: 10.1016/j.ejca.2016.11.010. [DOI] [PubMed] [Google Scholar]
  • 16.Schutte HW, Heutink F, Wellenstein DJ, van den Broek GB, van den Hoogen FJA, Marres HAM, et al. Impact of time to diagnosis and treatment in head and neck cancer:A systematic review. Otolaryngol-Head Neck Surg. 2020;162:446–57. doi: 10.1177/0194599820906387. [DOI] [PubMed] [Google Scholar]
  • 17.Wildt J, Bundgaard T, Bentzen SM. Delay in the diagnosis of oral squamous cell carcinoma. Clin Otolaryngol. 1995;20:21–5. doi: 10.1111/j.1365-2273.1995.tb00006.x. [DOI] [PubMed] [Google Scholar]
  • 18.COVIDSurg Collaborative. Elective surgery cancellations due to the COVID-19 pandemic:Global predictive modelling to inform surgical recovery plans. Br J Surg. 2020;107:1440–9. doi: 10.1002/bjs.11746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sultania M, Muduly D, Imaduddin M, Kar M. Oral cancer surgery and covid pandemic –metronomic therapy shows a promising role while awaiting surgery. Oral Oncol. 2020;106:104814. doi: 10.1016/j.oraloncology.2020.104814. doi:10.1016/j.oraloncology. 2020.104814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Morrison DR, Gentile C, McCammon S, Buczek E. Head and neck oncologic surgery in the covid-19 pandemic:Our experience in a deep south tertiary care center. Head Neck. 2020;42:1471–6. doi: 10.1002/hed.26262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.de Almeida JR, Noel CW, Forner D, Zhang H, Nichols AC, Cohen MA, et al. Development and validation of a surgical prioritization and ranking tool and navigation aid for head and neck cancer (SPARTAN-HN) in a scarce resource setting:Response to the COVID-19 pandemic. Cancer. 2020;126:4895–904. doi: 10.1002/cncr.33114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zaid W, Schlieve T. The early efects of coronavirus disease-2019 on head and neck oncology and microvascular reconstruction practice:A national survey of oral and maxillofacial surgeons enrolled in the head and neck special interest group. J Oral Maxillofac Surg. 2020;78:1859–68. doi: 10.1016/j.joms.2020.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ohlstein JF, Garner J, Takashima M. Telemedicine in otolaryngology in the COVID-19 era:Initial lessons learned. Laryngoscope. 2020;130:2568–73. doi: 10.1002/lary.29030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Brar S, Ofo E, Hyde N, Kim D, Odutoye T, Allin D, et al. Outcomes of elective head and neck confrmed or suspected cancer surgery during the COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2020;15:1–6. doi: 10.1007/s00405-020-06194-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mueller SK, Traxdorf M, Mantsopoulos K, Gostian AO, Sievert M, Koch M, et al. Considerations for continuing semielective and emergency otolaryngological procedures during the COVID-19 pandemic. Ear Nose Throat J. 2021;100:19–25. doi: 10.1177/0145561320952506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Valentini V, Pucci R, Battisti A, Cassoni A. Head and neck cancer cannot wait for this pandemic to end:Risks, challenges and perspectives of oral-maxillofacial surgeon during COVID-19. Oral Oncol. 2020;106:104758. doi: 10.1016/j.oraloncology.2020.104758. doi:10.1016/j.oraloncology.2020.104758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Riva G, Pizzo C, Fassone E, Pecorari G. Head and neck cancer surgery in covid-19 pandemic in Northern Italy. Oral Oncol. 2020;107:104835. doi: 10.1016/j.oraloncology.2020.104835. doi: 10.1016/j.oraloncology. 2020.104835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Galli J, Settimi S, Tricarico L, Almadori G, Paludetti G. Clinical and surgical management of patients with head and neck cancer in a covid-19 dedicated center in Italy. Head Neck. 2020;42:1466–70. doi: 10.1002/hed.26263. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Pharmacy & Bioallied Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES